web analytics

Why Avenue Therapeutics Stock’s (NASDAQ:ATXI) 107% Moonshot is Probably an Illusion

A press release reveals that, on July 25, Avenue Therapeutics’ shareholders approved a 1-for-15 reverse split of the company’s common stock.